Scientists launch massive GIST registry to unlock secrets of rare cancer
NCT ID NCT07273045
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This registry study will collect medical information and biological samples from 1,000 people with gastrointestinal stromal tumors (GIST), a rare type of digestive tract cancer. The goal is to better understand how GIST behaves, especially in rare forms, and to identify factors that lead to treatment resistance or recurrence. No new treatments or extra procedures are involved—participants continue their usual care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this registry could help researchers identify risk factors and design better treatments for rare forms of GIST.
What could go wrong
This is an observational registry, not a treatment trial. It will not directly benefit participants and may take years to yield useful results.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GIST - GASTROINTESTINAL STROMAL TUMOR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University Hospital Essem
Essen, North Rhine-Westphalia, 45147, Germany
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact